World's Best Scientists 2026 revealed!
Heather A. Wakelee

Heather A. Wakelee

D-Index & Metrics

Medicine

D-Index
91
Citations
35558
World Ranking
11635
National Ranking
5967

Heather A. Wakelee publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Heather A. Wakelee sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 898 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Heather A. Wakelee D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Heather A. Wakelee sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Heather A. Wakelee is affiliated with Stanford University in the United States and has made significant contributions primarily in the field of Medicine with a strong focus on Pulmonary and Respiratory Medicine and Oncology. Their research covers various subfields, including Cancer Research, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

The main topics in their body of work include:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Radiomics and Machine Learning in Medical Imaging

Wakelee has an extensive publication record in well-known outlets. Frequent publication venues for their work include:

  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Clinical Lung Cancer
  • JTO Clinical and Research Reports
  • Annals of Oncology

The scientist has co-authored with multiple researchers repeatedly, including Joel W. Neal, Sukhmani K. Padda, Jacqueline V. Aredo, Kavitha Ramchandran, and Millie Das.

Among recent publications associated with or closely related to their research, the following notable papers stand out:

  • Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer, 2023, New England Journal of Medicine
  • Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial, 2021, The Lancet
  • Integrating genomic features for non-invasive early lung cancer detection, 2020, Nature
  • COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study, 2020, The Lancet Oncology
  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer, 2021, Journal of Thoracic Oncology

Best Publications

  • An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

    Aaron M Newman;Scott V Bratman;Jacqueline To;Jacob F Wynne

  • Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

    J. Mazieres;A. Drilon;A. Lusque;L. Mhanna

  • Integrated digital error suppression for improved detection of circulating tumor DNA

    Aaron M Newman;Alexander F Lovejoy;Daniel M Klass;David M Kurtz

  • Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.

    Enriqueta Felip;Nasser Altorki;Caicun Zhou;Tibor Csőszi

  • Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

    Aadel A. Chaudhuri;Jacob J. Chabon;Alexander F. Lovejoy;Aaron M. Newman

  • Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

    Lecia V. Sequist;Jean Charles Soria;Jonathan W. Goldman;Heather A. Wakelee

  • Lung Cancer Incidence in Never Smokers

    Heather A. Wakelee;Ellen T. Chang;Scarlett L. Gomez;Theresa H. M. Keegan

  • American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

    Vicki Leigh Keedy;Sarah Temin;Mark R. Somerfield;Mary Beth Beasley

  • Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

    Jacob J. Chabon;Andrew D. Simmons;Alexander F. Lovejoy;Mohammad S. Esfahani

  • Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

    Christian Rolfo;Philip C. Mack;Giorgio V. Scagliotti;Paul Baas

  • COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.

    Marina Chiara Garassino;Jennifer G. Whisenant;Li Ching Huang;Annalisa Trama

  • First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.

    Branimir I. Sikic;Nehal Lakhani;Amita Patnaik;Sumit A. Shah

  • Integrating genomic features for non-invasive early lung cancer detection

    Jacob J. Chabon;Emily G. Hamilton;David M. Kurtz;Mohammad S. Esfahani

  • Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor

    Zofia Piotrowska;Matthew J. Niederst;Chris A. Karlovich;Heather A. Wakelee

  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    Christian Rolfo;Philip Mack;Giorgio V. Scagliotti;Charu Aggarwal

  • Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2

    Lucio Crinò;Myung Ju Ahn;Filippo De Marinis;Harry J. M. Groen

  • Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

    Rowan T. Chlebowski;Ann G. Schwartz;Heather Wakelee;Garnet L. Anderson

  • EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

    Nicolas Marcoux;Scott N. Gettinger;Grainne O’Kane;Kathryn C. Arbour

  • Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry

    Oliver Gautschi;Julie Milia;Thomas Filleron;Juergen Wolf

  • An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers

    Quynh-Thu Le;Eunice Chen;Ali Salim;Hongbin Cao

Frequent Co-Authors

Maximilian Diehn
Maximilian Diehn Stanford University
Leora Horn
Leora Horn Vanderbilt University Medical Center
Lecia V. Sequist
Lecia V. Sequist Harvard University
Ash A. Alizadeh
Ash A. Alizadeh Stanford University
David R. Gandara
David R. Gandara University of California, Davis
D. Ross Camidge
D. Ross Camidge University of Colorado Anschutz Medical Campus
Suresh S. Ramalingam
Suresh S. Ramalingam Emory University
Tony Mok
Tony Mok Chinese University of Hong Kong
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't always mean becoming a doctor. There are several flexible and accessible online programs for students interested in healthcare careers. For those without a nursing background, online bsn programs for non nurses offer a pathway to enter the nursing field efficiently while accommodating busy schedules.

If you prefer working behind the scenes in healthcare, consider exploring online medical billing and coding with financial aid. This option is great for students seeking administrative roles and the flexibility of remote work.

Aspiring practical nurses can benefit from programs like an lpn program no entrance exam, which removes common barriers and accelerates entry into the workforce.

For those aiming for leadership or management positions, an healthcare administration accelerated degree provides a fast track to a wide range of roles in hospital or clinical management, aligning with the industry's growing demand.

Best Scientists Citing Heather A. Wakelee

Trending Scientists

Recently Published Articles